Belmont Medical Technologies Receives $221K in Training Grant via via the Commonwealth of Massachusetts’ Workforce Training Fund Program

March 17, 2021

Belmont Medical Technologies notes the grant funding was awarded via the Commonwealth of Massachusetts’ Workforce Training Fund Program.

Belmont Medical Technologies currently employs 187 associates, including 137 in Massachusetts.

The training plan made possible by this grant will focus on enhancing critical skills in the areas of Lean Principles, People Management, and Train the Trainer to further develop and sustain Operational Excellence at Belmont’s 56,000 square foot facility. The grant will be administered over a 2-year period and has been matched by Belmont.

Brian Ellacott, Chief Executive Officer, Belmont, stated “One of Belmont’s core values is to ’embrace learning and growth’. This grant award goes a long way to support our efforts in this area. We are grateful to be one of the grant recipients and remain committed to creating jobs in the Commonwealth of Massachusetts and to enhancing our employees’ skills”.

This project is funded by a Workforce Training Fund grant from the Commonwealth of Massachusetts, Executive Office of Labor and Workforce Development. The grant program is administered by Commonwealth Corporation.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version